Sonic Research Development vs Total Revenue Analysis

SHL Stock

28.57 0.02 0.07%

Sonic Healthcare financial indicator trend analysis is much more than just breaking down Sonic Healthcare prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Sonic Healthcare is a good investment. Please check the relationship between Sonic Healthcare Research Development and its Total Revenue accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sonic Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Research Development vs Total Revenue

Research Development vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Sonic Healthcare Research Development account and Total Revenue. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Sonic Healthcare's Research Development and Total Revenue is 0.47. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Sonic Healthcare, assuming nothing else is changed. The correlation between historical values of Sonic Healthcare's Research Development and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Sonic Healthcare are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Research Development i.e., Sonic Healthcare's Research Development and Total Revenue go up and down completely randomly.

Correlation Coefficient

0.47

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Research Development

Total Revenue

Total revenue comprises all receipts Sonic Healthcare generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most indicators from Sonic Healthcare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Sonic Healthcare current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sonic Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, Sonic Healthcare's Selling General Administrative is comparatively stable compared to the past year. Tax Provision is likely to gain to about 252.9 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 181.1 M in 2024.

	2021	2022	2023	2024 (projected)
Interest Expense	79.8M	87.0M	151.3M	158.9M
Depreciation And Amortization	675.4M	702.9M	777.3M	816.2M

Interest Expense Depreciation And Amortization

Sonic Healthcare fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets
Total Assets		0.93	0.67	0.94	0.99	0.97	0.23	0.87	0.91	0.71	0.84	1.0	-0.53	0.84	0.98	0.98	0.97	0.3	0.95	0.97	-0.27	0.98	0.87	0.98	0.47	0.44
Short Long Term Debt Total	0.93		0.71	0.89	0.87	0.87	0.08	0.98	0.73	0.81	0.8	0.92	-0.33	0.8	0.91	0.94	0.93	0.14	0.95	0.83	-0.05	0.97	0.83	0.92	0.57	0.26
Other Current Liab	0.67	0.71		0.73	0.65	0.57	-0.54	0.7	0.52	0.34	0.57	0.67	-0.07	0.57	0.65	0.73	0.71	0.13	0.56	0.58	-0.01	0.68	0.56	0.66	0.65	-0.15
Total Current Liabilities	0.94	0.89	0.73		0.92	0.91	0.1	0.82	0.83	0.73	0.85	0.94	-0.5	0.85	0.94	0.92	0.94	0.3	0.86	0.92	-0.15	0.94	0.81	0.95	0.7	0.44
Total Stockholder Equity	0.99	0.87	0.65	0.92		0.96	0.24	0.82	0.95	0.66	0.78	0.99	-0.51	0.78	0.98	0.97	0.95	0.29	0.91	0.97	-0.33	0.94	0.87	0.96	0.43	0.43
Property Plant And Equipment Net	0.97	0.87	0.57	0.91	0.96		0.37	0.8	0.94	0.63	0.83	0.97	-0.6	0.83	0.96	0.92	0.89	0.36	0.95	0.98	-0.3	0.95	0.9	0.96	0.38	0.51
Current Deferred Revenue	0.23	0.08	-0.54	0.1	0.24	0.37		0.03	0.36	0.23	0.2	0.23	-0.51	0.2	0.26	0.11	0.11	0.22	0.34	0.35	-0.21	0.21	0.28	0.24	-0.39	0.65
Net Debt	0.87	0.98	0.7	0.82	0.82	0.8	0.03		0.69	0.8	0.66	0.88	-0.15	0.66	0.87	0.91	0.9	-0.01	0.89	0.76	0.01	0.91	0.84	0.84	0.54	0.1
Retained Earnings	0.91	0.73	0.52	0.83	0.95	0.94	0.36	0.69		0.5	0.65	0.92	-0.5	0.65	0.92	0.88	0.82	0.29	0.82	0.93	-0.4	0.84	0.89	0.86	0.27	0.41
Accounts Payable	0.71	0.81	0.34	0.73	0.66	0.63	0.23	0.8	0.5		0.61	0.71	-0.26	0.61	0.7	0.74	0.79	-0.05	0.74	0.59	-0.07	0.75	0.59	0.69	0.62	0.41
Cash	0.84	0.8	0.57	0.85	0.78	0.83	0.2	0.66	0.65	0.61		0.82	-0.75	1.0	0.77	0.77	0.8	0.55	0.85	0.83	-0.22	0.88	0.58	0.92	0.49	0.64
Non Current Assets Total	1.0	0.92	0.67	0.94	0.99	0.97	0.23	0.88	0.92	0.71	0.82		-0.51	0.82	0.98	0.98	0.97	0.28	0.95	0.97	-0.28	0.98	0.88	0.98	0.46	0.42
Non Currrent Assets Other	-0.53	-0.33	-0.07	-0.5	-0.51	-0.6	-0.51	-0.15	-0.5	-0.26	-0.75	-0.51		-0.75	-0.45	-0.39	-0.41	-0.69	-0.55	-0.63	0.48	-0.52	-0.22	-0.61	-0.03	-0.92
Cash And Short Term Investments	0.84	0.8	0.57	0.85	0.78	0.83	0.2	0.66	0.65	0.61	1.0	0.82	-0.75		0.77	0.77	0.8	0.55	0.85	0.83	-0.22	0.88	0.58	0.92	0.49	0.64
Net Receivables	0.98	0.91	0.65	0.94	0.98	0.96	0.26	0.87	0.92	0.7	0.77	0.98	-0.45	0.77		0.97	0.96	0.23	0.93	0.96	-0.15	0.96	0.9	0.96	0.46	0.38
Good Will	0.98	0.94	0.73	0.92	0.97	0.92	0.11	0.91	0.88	0.74	0.77	0.98	-0.39	0.77	0.97		0.98	0.19	0.92	0.92	-0.23	0.96	0.86	0.95	0.51	0.31
Common Stock Total Equity	0.97	0.93	0.71	0.94	0.95	0.89	0.11	0.9	0.82	0.79	0.8	0.97	-0.41	0.8	0.96	0.98		0.19	0.9	0.91	-0.18	0.96	0.79	0.95	0.57	0.36
Common Stock Shares Outstanding	0.3	0.14	0.13	0.3	0.29	0.36	0.22	-0.01	0.29	-0.05	0.55	0.28	-0.69	0.55	0.23	0.19	0.19		0.29	0.39	-0.25	0.3	0.08	0.39	-0.02	0.55
Non Current Liabilities Total	0.95	0.95	0.56	0.86	0.91	0.95	0.34	0.89	0.82	0.74	0.85	0.95	-0.55	0.85	0.93	0.92	0.9	0.29		0.91	-0.2	0.98	0.84	0.96	0.36	0.46
Inventory	0.97	0.83	0.58	0.92	0.97	0.98	0.35	0.76	0.93	0.59	0.83	0.97	-0.63	0.83	0.96	0.92	0.91	0.39	0.91		-0.27	0.94	0.84	0.97	0.37	0.54
Other Stockholder Equity	-0.27	-0.05	-0.01	-0.15	-0.33	-0.3	-0.21	0.01	-0.4	-0.07	-0.22	-0.28	0.48	-0.22	-0.15	-0.23	-0.18	-0.25	-0.2	-0.27		-0.17	-0.12	-0.21	0.11	-0.46
Total Liab	0.98	0.97	0.68	0.94	0.94	0.95	0.21	0.91	0.84	0.75	0.88	0.98	-0.52	0.88	0.96	0.96	0.96	0.3	0.98	0.94	-0.17		0.84	0.99	0.51	0.43
Property Plant And Equipment Gross	0.87	0.83	0.56	0.81	0.87	0.9	0.28	0.84	0.89	0.59	0.58	0.88	-0.22	0.58	0.9	0.86	0.79	0.08	0.84	0.84	-0.12	0.84		0.81	0.4	0.16
Total Current Assets	0.98	0.92	0.66	0.95	0.96	0.96	0.24	0.84	0.86	0.69	0.92	0.98	-0.61	0.92	0.96	0.95	0.95	0.39	0.96	0.97	-0.21	0.99	0.81		0.49	0.51
Short Term Debt	0.47	0.57	0.65	0.7	0.43	0.38	-0.39	0.54	0.27	0.62	0.49	0.46	-0.03	0.49	0.46	0.51	0.57	-0.02	0.36	0.37	0.11	0.51	0.4	0.49		0.09
Intangible Assets	0.44	0.26	-0.15	0.44	0.43	0.51	0.65	0.1	0.41	0.41	0.64	0.42	-0.92	0.64	0.38	0.31	0.36	0.55	0.46	0.54	-0.46	0.43	0.16	0.51	0.09

Click cells to compare fundamentals

Sonic Healthcare Account Relationship Matchups

Sonic Healthcare fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	12.6B	12.3B	13.1B	13.6B	14.8B	15.6B
Short Long Term Debt Total	4.6B	3.2B	3.0B	3.1B	4.5B	4.7B
Other Current Liab	899.8M	930.2M	749.9M	834.1M	1.3B	1.4B
Total Current Liabilities	2.1B	2.2B	2.1B	1.9B	2.3B	2.4B
Total Stockholder Equity	5.6B	6.4B	7.3B	7.7B	7.9B	8.3B
Property Plant And Equipment Net	2.5B	2.6B	2.6B	2.8B	3.1B	3.2B
Current Deferred Revenue	145.2M	254.7M	374.3M	220.6M	27.5M	28.9M
Net Debt	3.4B	2.3B	2.2B	2.3B	3.9B	4.1B
Retained Earnings	1.4B	2.3B	3.4B	3.6B	3.6B	3.7B
Accounts Payable	362.0M	225.3M	243.8M	255.8M	313.5M	329.2M
Cash	1.2B	899.8M	780.0M	798.0M	645.0M	677.3M
Non Current Assets Total	10.2B	10.0B	10.8B	11.4B	12.5B	13.1B
Non Currrent Assets Other	(6.5B)	(6.2B)	(6.8B)	(7.2B)	31.0M	32.6M
Cash And Short Term Investments	1.2B	899.8M	780.0M	798.0M	645.0M	677.3M
Net Receivables	986.8M	1.1B	1.2B	1.0B	1.4B	1.4B
Good Will	6.5B	6.2B	6.9B	7.2B	8.4B	8.8B
Common Stock Shares Outstanding	477.2M	481.5M	482.9M	472.4M	477.0M	342.3M
Liabilities And Stockholders Equity	12.6B	12.3B	13.1B	13.6B	14.8B	15.6B
Non Current Liabilities Total	4.9B	3.5B	3.6B	3.8B	4.4B	4.7B
Inventory	163.4M	224.4M	216.2M	199.2M	208.8M	219.3M
Other Stockholder Equity	(147K)	(140K)	(5.9M)	(7.4B)	(6.6M)	(6.9M)
Total Liab	7.0B	5.8B	5.7B	5.6B	6.8B	7.1B
Property Plant And Equipment Gross	2.5B	2.6B	2.6B	2.8B	5.7B	6.0B
Total Current Assets	2.5B	2.3B	2.3B	2.1B	2.4B	2.5B
Accumulated Other Comprehensive Income	175.4M	(19.2M)	61.2M	339.9M	224.4M	235.7M
Short Term Debt	663.1M	553.0M	342.1M	347.2M	661.0M	694.1M
Intangible Assets	7.0B	6.7B	7.4B	7.8B	721.1M	685.1M
Common Stock	4.0B	4.1B	3.9B	3.8B	4.1B	4.4B
Other Liab	439.8M	355.3M	368.7M	460.7M	529.8M	556.3M
Other Assets	127.3M	103.1M	259.8M	2.0	2.3	2.18
Long Term Debt	2.9B	1.6B	1.6B	1.7B	2.7B	1.6B
Other Current Assets	74.8M	71.6M	92.3M	113.8M	137.0M	143.8M
Property Plant Equipment	2.5B	2.6B	2.6B	2.8B	3.2B	3.4B
Net Tangible Assets	(1.4B)	(327.3M)	(88.3M)	(53.1M)	(61.1M)	(64.1M)
Long Term Investments	91.8M	108.1M	145.2M	175.8M	198.3M	107.2M
Short Long Term Debt	824.9M	364.2M	228.9M	297.5M	267.7M	443.2M
Long Term Debt Total	4.0B	2.7B	2.7B	2.8B	3.2B	2.9B
Treasury Stock	(680K)	(209K)	(147K)	(140K)	(126K)	(132.3K)
Capital Lease Obligations	1.4B	1.4B	1.4B	1.4B	1.5B	988.9M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Sonic Stock Analysis

When running Sonic Healthcare's price analysis, check to measure Sonic Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sonic Healthcare is operating at the current time. Most of Sonic Healthcare's value examination focuses on studying past and present price action to predict the probability of Sonic Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sonic Healthcare's price. Additionally, you may evaluate how the addition of Sonic Healthcare to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC